Cefixime Safety in Coronary Artery Disease Patients

Pharmacokinetic Considerations

The European Heart Journal recommends monitoring renal function in patients with chronic kidney disease (CKD), as cefixime clearance decreases with declining creatinine clearance, becoming statistically significant when creatinine clearance falls below 20 mL/min/1.73 m² 1

The European Heart Journal and the Journal of the American College of Cardiology suggest that CAD patients typically require multiple cardiovascular medications, and cefixime does not interfere with these essential therapies, including antiplatelet agents, beta-blockers, ACE inhibitors/ARBs, and statins 1, 2, 3
The European Heart Journal recommends that patients should continue their primary CAD medications without interruption while taking cefixime 1, 3